StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Emmaus Life Sciences's pe ratio was 43.4× on Apr 30, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 202143.4×−520.9
2013Oct 31, 2013564.3×–

More Emmaus Life Sciences figures

See a number that looks wrong?